Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Jun;106(2):443–446. doi: 10.1111/j.1476-5381.1992.tb14353.x

The effects of idazoxan and other alpha 2-adrenoceptor antagonists on urine output in the rat.

H C Jackson 1, I J Griffin 1, S D Birkett 1, D J Nutt 1
PMCID: PMC1907495  PMID: 1356562

Abstract

1. In normally-hydrated Wistar rats the alpha 2-adrenoceptor antagonist, idazoxan (1, 3, 10 mg kg-1 i.p.), increased urine output during the 6 h following injection. 2. The more selective and specific alpha 2-adrenoceptor antagonist, RX811059 (0.3, 1, 3 mg kg-1 i.p.), and the peripherally-acting alpha 2-adrenoceptor antagonist, L-659,066 (1, 3, 10 mg kg-1 i.p.), had no effect on urine output in normally-hydrated animals. 3. In rats given a 25 ml kg-1 water-load orally, idazoxan (10 mg kg-1, i.p.) produced an initial antidiuretic response which was followed by an increase in urine output which was apparent 4 and 6 h after drug administration. 4. RX811059 (1, 3 mg kg-1 i.p.) and L-659,066 (3, 10 mg kg-1 i.p.) significantly decreased urine output in water-loaded rats in the 2 h after injection. 5. The antidiuretic effects of L-659,066 were attenuated in Brattleboro rats which are deficient in vasopressin; only the highest dose (10 mg kg-1 i.p.) decreased urine output, and this was only a small response in comparison with its virtual abolition of urine output in water-loaded Wistar rats. 6. The results with the selective alpha 2-adrenoceptor antagonists in Wistar and Brattleboro rats suggest that alpha 2-adrenoceptors in the periphery may play a physiological role in the control of water balance through a mechanism which involves vasopressin. 7. The paradoxical diuretic effects of idazoxan contrast with the effects of the other alpha 2-adrenoceptor antagonists and therefore may be attributed to a property of this compound unrelated to alpha 2-adrenoceptor blockade.

Full text

PDF
443

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bianchi G. Antidiuretic effect of bremazocine and U-50,488 in rats after alpha 2-adrenoceptor blockade. J Pharm Pharmacol. 1991 Mar;43(3):212–216. doi: 10.1111/j.2042-7158.1991.tb06670.x. [DOI] [PubMed] [Google Scholar]
  2. Blackburn T. P., Borkowski K. R., Friend J., Rance M. J. On the mechanisms of kappa-opioid-induced diuresis. Br J Pharmacol. 1986 Nov;89(3):593–598. doi: 10.1111/j.1476-5381.1986.tb11160.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown C. M., MacKinnon A. C., McGrath J. C., Spedding M., Kilpatrick A. T. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain. Br J Pharmacol. 1990 Apr;99(4):803–809. doi: 10.1111/j.1476-5381.1990.tb13010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chapleo C. B., Myers P. L., Butler R. C., Doxey J. C., Roach A. G., Smith C. F. alpha-adrenoreceptor reagents. 1. Synthesis of some 1,4-benzodioxans as selective presynaptic alpha 2-adrenoreceptor antagonists and potential antidepressants. J Med Chem. 1983 Jun;26(6):823–831. doi: 10.1021/jm00360a008. [DOI] [PubMed] [Google Scholar]
  5. Clineschmidt B. V., Pettibone D. J., Lotti V. J., Hucker H. B., Sweeney B. M., Reiss D. R., Lis E. V., Huff J. R., Vacca J. A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066. J Pharmacol Exp Ther. 1988 Apr;245(1):32–40. [PubMed] [Google Scholar]
  6. Gellai M. Modulation of vasopressin antidiuretic action by renal alpha 2-adrenoceptors. Am J Physiol. 1990 Jul;259(1 Pt 2):F1–F8. doi: 10.1152/ajprenal.1990.259.1.F1. [DOI] [PubMed] [Google Scholar]
  7. Goldberg M. R., Robertson D. Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor. Pharmacol Rev. 1983 Sep;35(3):143–180. [PubMed] [Google Scholar]
  8. Jackson H. C., Griffin I. J., Nutt D. J. The effects of idazoxan and other alpha 2-adrenoceptor antagonists on food and water intake in the rat. Br J Pharmacol. 1991 Sep;104(1):258–262. doi: 10.1111/j.1476-5381.1991.tb12416.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Langin D., Paris H., Lafontan M. Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites. Mol Pharmacol. 1990 Jun;37(6):876–885. [PubMed] [Google Scholar]
  10. Michel M. C., Brodde O. E., Schnepel B., Behrendt J., Tschada R., Motulsky H. J., Insel P. A. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. Mol Pharmacol. 1989 Mar;35(3):324–330. [PubMed] [Google Scholar]
  11. Michel M. C., Insel P. A. Are there multiple imidazoline binding sites? Trends Pharmacol Sci. 1989 Sep;10(9):342–344. doi: 10.1016/0165-6147(89)90002-3. [DOI] [PubMed] [Google Scholar]
  12. Scatton B., Zivkovic B., Dedek J. Antidopaminergic properties of yohimbine. J Pharmacol Exp Ther. 1980 Nov;215(2):494–499. [PubMed] [Google Scholar]
  13. limberger N., Starke K. Partial agonist effect of 2-[2-(1,4-benzodioxanyl)]-2-imidazoline (RX 781 094) at presynaptic alpha 2-adrenoceptors in rabbit ear artery. Naunyn Schmiedebergs Arch Pharmacol. 1983 Sep;324(1):75–78. doi: 10.1007/BF00647842. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES